Meet our Board of Directors


Gordon Amidon, Ph.D., Chairman of the Board & CSO

Dr. Gordon Amidon is an internationally recognized expert in the fields of solubility, transport phenomena, prodrugs, and drug absorption.  He has been actively involved with the development of the Biopharmaceutics Classification System (BCS) with the FDA (BCS serves as a basis for international drug regulation).  Gordon received his Ph.D. in Pharmaceutical Chemistry from the University of Michigan. He has held the following positions; faculty at the University of Wisconsin, Director of Pharmaceutical Research at Merck / INTERx, in Lawrence, Kansas and was appointed Professor of Pharmaceutics at the University of Michigan in 1983.  Gordon co-founded the Drug Delivery Foundation. His research is extensive, Gordon has over 300 published papers and has contributed chapters to more than 30 books and monographs.

Photo Credit University of Michigan

Photo Credit University of Michigan

Gregory (Greg) Amidon, Ph.D.

Dr. Gregory Amidon is Research Professor of Pharmaceutical Sciences at the University of Michigan, College of Pharmacy.  Greg has 28 years of industrial experience holding various positions in R&D at leading pharmaceutical companies. He is recognized for his expertise in the physical, chemical, and mechanical property characterization of active pharmaceutical ingredients, excipients, and products as well as the development of scientific strategies for oral solid dosage form development and oral bioperformance.

Greg has served on the USP Council of Experts since 1990 and currently serves on the Board of Trustees. In 2015, Greg was elected President of the American Association of Pharmaceutical Scientists (AAPS). He is a recipient of the Ebert Prize from the American Pharmaceutical Association and the 2014 AAPS Research Achievement Award in Physical Pharmacy and Biopharmaceutics. Greg received his BS in Medicinal Chemistry and his PhD in Pharmaceutical Chemistry from the University of Michigan.


Elke Lipka

Elke Lipka, Ph.D., M.B.A.

Dr. Elke Lipka joined TSRL in June of 2007 to develop and implement a sustainable competitive commercialization strategy for TSRL’s technology portfolio.  She was promoted to CEO in November 2018. She received her B.S. in Pharmacy and Ph.D. in Pharmacology from the Johann-Wolfgang-von-Goethe University in Frankfurt, Germany, and her M.B.A. from the University of Michigan.

Elke started her career as a Research Scientist at TSRL in 1992 and subsequently has held a number of scientific and management positions of increasing responsibility at Parke-Davis, Pfizer, and Esperion Therapeutics. She is an experienced professional capable of building and managing multidisciplinary teams involved in the discovery and development of pharmaceutical drug candidates and drug delivery systems. Her expertise includes pharmacokinetic, drug metabolism and drug safety scientific guidance to small molecule and biologic drug development programs. Elke brings strong skills in project management, establishment of strategic partnerships, and management of financial and operational business aspects to TSRL.

Photo Credit Iowa State University

Photo Credit Iowa State University

Kevin Amidon, Ph.D.

Dr. Kevin Amidon is Associate Professor of German Studies in the Department of World Languages and Cultures at the Iowa State University, where he serves also as an affiliate member of the faculty in Women’s and Gender Studies. He studied German, economics, history, musicology, and art history in Ann Arbor, Freiburg, Princeton, Frankfurt am Main, and Berlin. He has published a wide range of articles on critical theory, gender history and theory, eugenics, race theory, evolutionary thought, the Frankfurt School, German and American history, opera, and theater. In 2015, he received the Cassling Family Faculty Award for teaching excellence from the College of Liberal Arts and Sciences at Iowa State. Kevin received his Ph.D. in Germanic Languages and Literature at Princeton University in 2001.

Eric Amidon.jpg

Eric Amidon

Mr. Eric Amidon is currently Director of Technology for Novitex Enterprise Solutions, a leading provider of cloud-based solutions in the document outsourcing industry. Prior to joining Novitex, Eric performed as a soloist with the Lawrence Symphony Orchestra and has since performed solo works with the Pioneer Symphony and DePauw Symphony Orchestras. He has participated in festivals throughout North America, including two years at the Orford Arts Festival. In addition to his position with the Ann Arbor Symphony Orchestra, Eric regularly plays regional engagements with chamber ensembles. Eric received his Bachelor of Arts in Music Performance from DePauw University in 1997.